Lower Limbs News
-
Caresyntax Announces Highlights of 2023
Caresyntax, the leading vendor of enterprise-scale data-driven surgical intelligence solutions to make surgery safer and smarter, today announced its highlights and achievements of 2023, as the company has continued its strong growth journey. Dennis Kogan, co-founder, and CEO: “Caresyntax celebrated its 10-year anniversary in 2023 and accelerated our journey of innovation and expansion ...
By Caresyntax
-
AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced the completion of patient enrollment in the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AV). APEX-AV is a ...
-
Caira Surgical to Participate in Upcoming Investor Conferences
Caira Surgical, the pioneer in radar surgical tracking for navigated and robotic joint replacement surgery, announced today that Jon Greenwald, Chief Executive Officer, and Irina Benimovich, Chief Financial Officer, will conduct investor meetings and host presentations at the upcoming CG 2023 Musculoskeletal Conference and LSI USA '23 partnering event. March 7 – CG 2023 Musculoskeletal ...
-
Healiva Acquires Two Wound-healing Cell Therapy Assets From Smith+Nephew
Healiva®, a patient-centric company delivering life-enhancing precision medicine for patients with chronic and acute wounds, announced today the acquisition of two innovative cell therapy assets from Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business. The acquisition enables Healiva® to establish one of the world’s broadest portfolios of affordable, ...
By healiva SA
-
On the road to IPO, Field Orthopaedics raises $5m for push into US
The rapidly growing Australian orthopaedics devices company, Field Orthopaedics (FO) has just completed a fresh round of fundraising, equipping it with $5million in new capital for a push into the US$11billion trauma and extremities market. As one of the fastest growing market sub-sectors, at a rate of 7-10% per annum, hand and wrist orthopaedics is now around 40% of the upper extremities market. ...
-
1st Patient treated with Vetex Thrombectomy Catheter
Vetex™ Medical Ltd., an innovator in deep vein thrombosis (DVT) treatment, announced it’s first patient on December 18th, 2018, treated in the VETEX (Venous Thrombus Extraction) Study, a first-in-man, multicenter study of the Vetex™ Thrombectomy Catheter. The Vetex device is the first DVT device to combine rotational and grasping action to quickly and gently remove large volumes ...
-
We continue testing HANK
In collaboration with CEIT, we have been carrying out different trials with our lower limb exoskeleton under the Eurobench project. The tests have been carried out in different environments such as: ramps, stairs, etc. The results have been very favourable, confirming the versatility of our lower limb exoskeleton. In addition, the test results will contribute to the improvement of walking ...
-
DIH-HERO project “EngageABLE”
We are pleased to announce that “EngageABLE”, a project of ABLE Human Motion in collaboration with the dutch hospital Sint Maartenskliniek, has been awarded for funding by DIH-HERO. The goal of this project is to enhance the capabilities of the ABLE Exoskeleton to promote users’ motivation and faster learning. DIH-HERO is an independent platform that connects Digital Innovation ...
-
Soundbite Medical Solutions Announces Issuance of Two New U.S. Patent Further Expanding Coverage of its Shock Wave Technology
Soundbite Medical Solutions Inc. (SBMS), a medical device company leveraging its proprietary shock wave technology for the interventional treatment of calcific occlusive peripheral and coronary arterial diseases, today announced that the United States Patent and Trademark Office has issued two additional US patents. Patent No. 11,419,619, entitled “Method and system for treating ...
-
Announcement – RSIP Vision Presents Successful Preliminary Results from Clinical Study of 2D-to-3D Knee Bones Reconstruction
RSIP Vision, an experienced developer of groundbreaking AI technologies for medical imaging, today reveals preliminary results from an ongoing clinical study for the evaluation of the reconstruction of a 3D knee model from 2D X-ray images at Assuta Medical Center in Tel Aviv. This tool is based on novel, patent-pending technology, implementing advanced artificial intelligence (AI) to produce an ...
By RSIP Vision
-
OSSIO Awarded FDA 510(k) Clearance for OSSIOfiber Compression Screw Portfolio
OSSIO, Inc., an orthopedic fixation technology company, today announced that its OSSIOfiber® Compression Screw Portfolio has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for maintenance of alignment and fixation of bone fractures, comminuted fractures, fragments, osteotomies, arthrodesis and bone grafts of the upper extremity, fibula, knee, ankle and foot ...
By OSSIO Inc
-
OSSIO Receives Vizient Contract for Bio-Integrative Orthopedic Fixation Technology
OSSIO, Inc., an orthopedic fixation technology company, today announced that it has received a contract with Vizient, Inc., making the company’s portfolio of bio-integrative OSSIOfiber products available at negotiated pricing to health care providers in Vizient’s group purchasing organization (GPO) under a three-year contract starting March 1. OSSIO’s contract with Vizient ...
By OSSIO Inc
-
Research Continues to Support the Benefits of Osso VR for Surgical Training
Osso VR, now the largest and fastest-growing virtual reality (VR) company in healthcare, today announced the results of a new study published in the Journal of Surgical Education demonstrating the effectiveness of VR training for medical residents learning complex orthopedic surgical procedures. The study, led by orthopedic surgeons at Community Memorial Health System in California, divided a ...
-
Photodisinfection successfully eradicates pathogens associated with replacement joint infections
A research team in Zurich, Switzerland has presented results from an in vitro study showing that photodisinfection achieved >99.99% eradication (4-7 log10 kill) of the key pathogens in biofilms associated with implantable joint infections, with no reported regrowth. These results were presented at the recent Swiss Society for Microbiology (SSM) Annual Congress 2022 in Lausanne, Switzerland. ...
-
enVVeno Medical Appoints Kevin Belteau as Vice President of Clinical Operations
IRVINE, CA / August 16, 2022 / enVVeno Medical Corporation (NASDAQ:NVNO) (“enVVeno” or the “Company”), a company setting new standards of care for the treatment of venous disease, today announced the appointment of Kevin Belteau as Vice President of Clinical Operations. Mr. Belteau joins enVVeno Medical following a twenty-three-year career in clinical operations at ...
-
THINK Surgical and Curexo Announce Entry Into Development and Distribution Agreement
(FREMONT, CA) August 1, 2022 – THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced its entry into a development and distribution agreement with Curexo, Inc., a medical robotics specialist company based in South Korea. THINK and Curexo have a strong working relationship based on historical development collaboration and Curexo distributes ...
-
enVVeno Medical Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Ended the quarter with $47.2 million in cash and investments – expected to fund operations through the end of 2024, including release of topline SAVVE pivotal trial data IRVINE, CA / August 3, 2022 / enVVeno Medical Corporation (NASDAQ:NVNO) (“enVVeno” or the “Company”), a company setting new standards of care for the treatment of venous disease, today provided a ...
-
Think Surgical Appoints Park Mehendale as Vice President of Operations
(FREMONT, CA) July 26, 2022?- THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced the appointment of Parikshit (Park) Mehendale as vice president of operations. Mr. Mehendale brings nearly 20 years of global operations, supply chain, and engineering management experience to the THINK organization. At THINK, Mr. Mehendale will lead supply chain, ...
-
The next evolution in blood vessel occlusion
The good news for his patient was that she was young. A lower extremity bypass procedure - like any surgery - can be more difficult as we age. The bad news was that the best veins for the procedure - which involves grafting a vein from another part of the body to bypass her blocked arteries in the leg - were unusable. The patient had undergone varicose vein treatments as a young woman that ...
-
Doug Kohrs appointed to Sequana Medical Board of Directors
Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the treatment of drug-resistant fluid overload in liver disease and heart failure, today announces the appointment of Doug Kohrs as an independent Non-Executive Director of the Company. Mr. Kohrs is a highly experienced US executive with a track record of more than 40 years in ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you